Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Viking Thera (NQ: VKTX ) 64.96 +0.85 (+1.33%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Viking Thera < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer October 04, 2024 Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention. Via Investor's Business Daily Why Viking Therapeutics Stock Topped the Market Today September 30, 2024 An analyst waxed bullish on the company's leading pipeline program. Via The Motley Fool Is Viking Therapeutics Stock a Buy? September 29, 2024 The company is in the spotlight for one of its programs, but it's got others that also have promise. Via The Motley Fool Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics September 28, 2024 One of them is performing much better than the other this year. Via The Motley Fool $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today September 27, 2024 Via Benzinga Why Viking Therapeutics Stock Was So Healthy on Wednesday September 25, 2024 Hardly for the first time, a pundit following the company waxed bullish on its future. Via The Motley Fool Viking Therapeutics Unusual Options Activity For September 24 September 24, 2024 Via Benzinga What the Options Market Tells Us About Viking Therapeutics September 17, 2024 Via Benzinga Viking Therapeutics Unusual Options Activity For September 11 September 11, 2024 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session September 23, 2024 Via Benzinga US Stocks Stall, Gold Updates Record Highs, Tesla Rallies: What's Driving Markets Monday? September 23, 2024 Wall Street kicked off the week on a cautious note, with major indexes trading relatively flat as investors seek more clarity on the economic and political landscape. Via Benzinga Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy? September 23, 2024 These two stocks could be rivals in the intense GLP-1 space in the future. Via The Motley Fool Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today September 20, 2024 The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout. Via The Motley Fool If You Invested $1000 In This Stock 5 Years Ago, You Would Have $7,500 Today September 06, 2024 Via Benzinga Jim Cramer: Viking Therapeutics Has 'Many Ships Coming In' September 20, 2024 Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts. Via Benzinga This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments September 18, 2024 Terns has a modest market cap of less than $800 million, and its possible upside could be massive. Via The Motley Fool Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 September 18, 2024 These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond. Via The Motley Fool 1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc) September 17, 2024 Telemedicine once seemed like it was going to revolutionize healthcare. Via The Motley Fool Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now. September 15, 2024 Terns Pharmaceuticals just proved that it's competitive in the weight loss field. Via The Motley Fool Stock Market Rally Revives; Apple iPhone 16, Nvidia, Oracle, Adobe In Focus: Weekly Review September 13, 2024 The major indexes reclaimed key levels and many leaders flashed buy signals. Via Investor's Business Daily These 2 Biotech Stocks Are Set to Soar September 13, 2024 Innovative drugmakers developing treatments for conditions with high unmet needs can produce lucrative wins. Via The Motley Fool Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735 September 13, 2024 Recently revealed trial results for Roche's experimental weight-management drug suggest Viking Therapeutics is on the right track. Via The Motley Fool Why Investors Plowed Into Viking Therapeutics Stock Today September 12, 2024 The company is looking especially good after some bad news coming from a rival. Via The Motley Fool 3 No-Brainer Biotech Stocks to Buy With $200 Right Now September 12, 2024 An investment in these players today could score a big win down the road. Via The Motley Fool Why Viking Therapeutics Stock Rocked the Market Today September 11, 2024 The biotech continued to get attention from both pundits and investors, thanks largely to its investigational obesity drug. Via The Motley Fool Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan September 11, 2024 JPMorgan analyst Hardik Parikh initiated coverage on Viking Therapeutics with an Overweight rating and a December 2025 price target of $80. Via Benzinga Novo Nordisk Jumps After New Weight-Loss Pill Tops Wegovy; Eli Lilly, Viking Shares Rise September 11, 2024 The company is working on a drug that targets GLP-1 and amylin to improve weight loss. Via Investor's Business Daily Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead? September 07, 2024 The huge demand for effective new weight management drugs has billionaire investors feeling bullish about this stock. Via The Motley Fool Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern September 05, 2024 Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation. Other drugs also affected. Via Benzinga Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year September 05, 2024 Nvidia is heading for a 118% gain this year. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.